Vital Farms (VITL)
(Delayed Data from NSDQ)
$34.72 USD
-0.64 (-1.81%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $34.72 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.72 USD
-0.64 (-1.81%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $34.72 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth C Momentum B VGM
Zacks News
Kellogg (K) Benefits From Portfolio Strength & Acquisitions
by Zacks Equity Research
Kellogg (K) is dedicated to augmenting its portfolio by adding more products under existing brands, innovation and marketing initiatives.
Here's Why FEMSA (FMX) is Marching Ahead of Its Industry
by Zacks Equity Research
FEMSA (FMX) looks good on continued growth in the digital business, as well as strength across all segments. The expansion strategy of its national distribution platform bodes well.
The Zacks Analyst Blog Highlights Hershey's, General Mills, Mondelez and Vital Farms
by Zacks Equity Research
Hershey's, General Mills, Mondelez and Vital Farms are included in this Analyst Blog.
4 Stocks to Buy on Rebound in March Consumer Confidence
by Ritujay Ghosh
Consumer confidence is rebounding, but the crisis is far from over. Investing in consumer staple stocks like The Hershey Company (HSY), General Mills (GIS), Mondelez International (MDLZ) and Vital Farms (VITL) would be a wise decision.
McCormick (MKC) Q1 Earnings Top Estimates, Sales Increase Y/Y
by Zacks Equity Research
McCormick's (MKC) first-quarter fiscal 2023 results reflect gains from higher pricing along with the impacts of the Kitchen Basics divestiture, pandemic-led reduced consumption in China and cost inflation.
Helen of Troy (HELE) Gains on Leadership Brands, Hurt by Costs
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from its solid Leadership Brands and a focus on Project Pegasus, while escalated costs and softness in the Beauty segment are concerns.
Monster Beverage (MNST) Rises 30% in a Year: More Upside Left?
by Zacks Equity Research
Despite elevated costs and currency woes, Monster Beverage's (MNST) continued momentum in the energy drinks category and a robust pipeline of new products are likely to drive growth.
Altria's (MO) Smoke-Free Products Aid Amid Low Cigarette Volume
by Zacks Equity Research
Altria (MO) has been benefiting from its Oral Tobacco Products and strong pricing power. However, soft volumes in the Smokeable Products segment are a concern.
General Mills (GIS) Raises Guidance Again on Q3 Earnings Beat
by Zacks Equity Research
General Mills' (GIS) third-quarter fiscal 2023 results reflect solid earnings and sales, leading to raised guidance. The company focuses on its Accelerate strategy.
Conagra Brands' (CAG) Pricing Efforts Bode Well Amid Cost Woes
by Zacks Equity Research
Conagra Brands' (CAG) robust pricing endeavors have been aiding the company amid cost headwinds. A focus on innovation has also been a driver.
Vital Farms (VITL) Misses Q4 Earnings Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of -20% and 4.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Vital Farms (VITL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Vital Farms (VITL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How AB InBev (BUD) Looks Just Ahead of Q4 Earnings
by Zacks Equity Research
AB InBev (BUD) Q4 results are expected to reflect gains from continued business momentum, premiumization and digital growth, offset by adverse currency rates, commodity costs and supply-chain costs.
The J.M. Smucker (SJM) Readies for Q3 Earnings: Things to Note
by Zacks Equity Research
The J.M. Smucker's (SJM) third-quarter results are likely to reflect the adverse impacts of cost inflation, while pricing efforts and strength in the coffee business bode well.
Inter Parfums (IPAR) Queued for Q4 Earnings: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2022 performance will likely reflect solid sales, owing to higher U.S.-based and Europe-based product sales.
Know What's in Store for Monster Beverage (MNST) in Q4 Earnings
by Zacks Equity Research
Monster Beverage (MNST) Q4 results are expected to reflect gains from strength in the energy drinks business, continued pricing actions to wean inflationary costs and product innovation.
Medifast (MED) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 69.72% and 9.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Beyond Meat (BYND) in Q4 Earnings?
by Zacks Equity Research
Beyond Meat's (BYND) fourth-quarter 2022 performance is likely to reflect the impact of higher inflation. Nevertheless, its focus on curtailing operating expenses is an upside.
Why FEMSA (FMX) Looks Poised for an Earnings Beat in Q4
by Zacks Equity Research
FEMSA's (FMX) Q4 results are expected to reflect gains from strong demand, growth in the digital business and expansion into the specialized distribution industry.
Things to Support Molson Coors' (TAP) Earnings Beat in Q4
by Zacks Equity Research
Molson Coors' (TAP) Q4 results are expected to reflect the benefits of pricing actions, the revitalization plan and the premiumization of its global portfolio.
Aramark (ARMK) Q1 Earnings Miss Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of -2.38% and 1.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Vital Farms (VITL): Can Its 6.8% Jump Turn into More Strength?
by Zacks Equity Research
Vital Farms (VITL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Beat the Market Like Zacks: JPMorgan Chase, Oracle, BioVie in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Vital Farms (VITL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 100% and 3.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include Vital Farms, Coupang and Webster Financial
by Zacks Equity Research
Vital Farms, Coupang and Webster Financial are part of the Zacks Screen of the Week article.